Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 116
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Do human activities increase antibiotic-resistant disease in Chilean penguins?

    Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...

    Are Implanted Prosthetic Legs for Horses Possible?

    An unacceptable number of otherwise healthy horses are euthanized each year from lower limb ailments for...

    Backer Badge Funded